Key facts
- SanaHeal’s last known valuation is $22.5M (Dec 2024).
- It has raised $14.3M; the latest was Later Stage VC ($10.5M) in Dec 2024.
- Notable investors include Creative Destruction Lab, MedTech Innovator, University of Toronto, University of Toronto Entrepreneurship, SBXi — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for SanaHeal
- ·The full record, as it builds
Funding rounds
No funding rounds for SanaHeal are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SanaHeal
Developer of bioadhesive medical technologies designed to achieve rapid and strong adhesion to wet and irregular tissue surfaces. The company offers nature-inspired adhesives modeled after barnacles and spider webs that clean and bond to uneven or contaminated areas, provide instant drying and secure attachment in moist environments, and undergo pre-clinical testing, enabling healthcare providers and medical device manufacturers to improve wound closure and tissue repair with materials that adhere effectively in challenging biological conditions.
- Sector
- Healthcare
- HQ
- Somerville, MA, United States
- Founded
- 2020
- Employees
- 8
- Website
- sanaheal.com/
- Ownership
- Privately Held (backing)
SanaHeal doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SanaHeal shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SanaHeal in its N-PORT filings yet. We sweep new filings monthly.